Correlation Between Unicycive Therapeutics and RenovoRx

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and RenovoRx, you can compare the effects of market volatilities on Unicycive Therapeutics and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and RenovoRx.

Diversification Opportunities for Unicycive Therapeutics and RenovoRx

0.69

Correlation Coefficient

Unicycive Therapeutics  RenovoRx

Poor diversification

The 3 months correlation between Unicycive and RenovoRx is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and RenovoRx go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and RenovoRx

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.38 times more return on investment than RenovoRx. However, Unicycive Therapeutics is 1.38 times more volatile than RenovoRx. It trades about 0.3 of its potential returns per unit of risk. RenovoRx is currently generating about 0.08 per unit of risk. If you would invest  36.00  in Unicycive Therapeutics on September 5, 2024 and sell it today you would earn a total of  35.00  from holding Unicycive Therapeutics or generate 97.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Unicycive Therapeutics  vs.  RenovoRx

Unicycive Therapeutics

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

RenovoRx

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Unicycive Therapeutics and RenovoRx

The main advantage of trading using opposite Unicycive Therapeutics and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.

The idea behind Unicycive Therapeutics and RenovoRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.